Spain
· Delayed Price · Currency is EUR Almirall Company Description
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism, anti-infective for systemic use, cardiovascular system, dermatological, genito urinary system and sex hormones, immunostimulants, metabolism, musculo-skeletal system, nervous system, respiratory system, systemic hormonal preparations.
It also develops tirbanibulin for actinic keratosis, and tildrakizumab for psoriatic arthritis under the registration phase, as well as lebrikizumab for atopic dermatitis pediatric in phase 2; Anti-IL-1RAP mAb for hidradenitis suppurativa, anti-IL-1RAP mAb for inflammatory skin disease, Anti-IL-21 mAb for hidradenitis suppurativa, IL-2muFc for alopecia areata, IL-2muFc for atopic dermatitis, and IL-2muFc for inflammatory skin disease in phase 2; readthrough inducer for rare dermatology in phase 1; and anti-IL-13/OX40L BsAb for atopic dermatitis, SMOL oral for Th2-driven diseases, and mRNA/LNP for non-melanoma skin cancer in preclinical stage.
It has research and development agreements with Evotec, Ichnos, Simcere, Etherna, Novo Nordisk, and Eloxx.
The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009.
Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
| Country | Spain |
| Founded | 1943 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,108 |
| CEO | Carlos Gallardo Piqué |
Contact Details
Address: Ronda General Mitre, 151 Barcelona, 08022 Spain | |
| Phone | 34 93 291 30 00 |
| Website | almirall.com |
Stock Details
| Ticker Symbol | ALM |
| Exchange | Madrid Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | ES0157097017 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Carlos Gallardo Piqué | Chief Executive Officer, President, Member of Management Board and Chairman of the Board |
| Jon U. Garay Alonso | Chief Financial Officer and Member of Management Board |
| Eloi Crespo Cervera | Chief Industrial Operations Officer and Member of Management Board |
| Esteve Conesa Panicot | Chief People and Culture Officer and Member of Management Board |
| Dr. Volker Koscielny | Chief Medical Officer and Member of Management Board |
| Dr. Karl Ziegelbauer | Chief Scientific Officer and Member of Management Board |
| Isabel Cristina Gomes | Company Vice Secretary,Chief Legal Officer, General Counsel and Member of Management Board |
| Paul Rittman | Member of Management Board and President and GM of Almirall US |
| Lidia Martin Pereda | Chief Commercial Officer of Europe and International and Member of Management Board |
| Pablo Divasson del Fraile | Senior Director of Investor Relations |